Generic makers will appeal ruling that allows California to proceed with law banning pay-to-delay deals

3 January 2020 - A federal judge dealt the pharmaceutical industry a setback by declining to block a new California ...

Read more →

North America trade pact deals rare setback to big pharma

19 December 2019 - A revamped North American trade deal nearing passage in Congress gives both the White House and ...

Read more →

Do large pharma companies provide drug development innovation? Our analysis says no.

10 December 2019 - Large pharmaceutical companies oppose legislation being considered by Congress to lower the prices of prescription drugs. ...

Read more →

Teva, drug makers in talks with U.S. to end generics probes

26 November 2019 - Deferred prosecution agreements among resolutions discussed. ...

Read more →

Speaker Pelosi’s drug pricing plan could result in 56 fewer new medicines over 10 years

21 November 2019 - International reference pricing provisions in plan would decimate development of innovative medicines by nearly 90%. ...

Read more →

Public sector financial support for late stage discovery of new drugs in the United States: cohort study

23 October 2019 - This study determined the extent to which late stage development of new drugs relies on support from ...

Read more →

Pelosi’s drug pricing plan puts medical innovation at risk

17 October 2019 - The future of medical innovation in America is at a crossroads. ...

Read more →

Pharma industry is 'right in the crosshairs,' Merck CEO Kenneth Frazier says

11 October 2019 - President Donald Trump and House Speaker Nancy Pelosi are in a battle over impeachment but their ...

Read more →

FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases

8 October 2019 - The U.S. FDA today announced that it has awarded 12 new clinical trial research grants totaling ...

Read more →

Right to try ‘remains a bust,’ as many drug makers prefer FDA reviews

12 September 2019 - Despite the hubbub over the “right-to-try” law, a recent survey found that nearly half of drug ...

Read more →

Big Pharma is abusing patents, and it's hurting Americans

12 September 2019 - The American patent system has, since our nation's founding, served as a cornerstone of innovation. But ...

Read more →

Are reasonable restraints on drug price increases doomed by pharma lobbying?

29 August 2019 - In a rare but important display of congressional bipartisanship, Senators Chuck Grassley (R-Iowa) and Ron Wyden ...

Read more →

Placebos and blinding in randomised controlled cancer clinical trials for drug and biological products: guidance for industry

28 August 2019 - This guidance provides recommendations to industry about the use of placebos and blinding in randomised controlled clinical ...

Read more →

Why America’s biggest charities are owned by pharmaceutical companies

13 August 2019 - Their generosity helps their bottom line. ...

Read more →

How pharma, under attack from all sides, keeps winning in Washington

16 July 2019 - It does not seem to matter how angrily President Trump tweets, how pointedly House Speaker Nancy ...

Read more →